Abstract
Cancer-associated fibroblasts (CAFs) play important roles in regulating tumor progression, metastasis, and response to therapies. Accurately modeling the interplay between cancer cells and the tumor microenvironment (TME) requires the use of primary cells from patient samples. Here we describe methods for the isolation of both primary CAFs and fibroblasts from omental tissue using a combination of mechanical dissociation and enzymatic digestion. Primary cells can be used for functional and mechanistic studies and may be safely cryopreserved.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y, Helou Y, Batlle R, Liu X, Gutierrez N, Gao X, Yamada SD, Lastra R, Montag A, Ahsan N, Locasale JW, Salomon AR, Nebreda AR, Lengyel E (2019) Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis. Cell Metab 29:141–155.e9. https://doi.org/10.1016/j.cmet.2018.08.007
Dasari S, Fang Y, Mitra AK (2018) Cancer associated fibroblasts: naughty neighbors that drive ovarian cancer progression. Cancers 10(11):406. https://doi.org/10.3390/cancers10110406
Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, Tienda SM, Nahotko DA, Li G, Blazenovic I, Lastra RR, Curtis M, Yamada SD, Perets R, McGregor SM, Andrade J, Fiehn O, Moellering RE, Mann M, Lengyel E (2019) Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Nature 569:723–728. https://doi.org/10.1038/s41586-019-1173-8
Wu RC, Wang P, Lin SF, Zhang M, Song Q, Chu T, Wang BG, Kurman RJ, Vang R, Kinzler K, Tomasetti C, Jiao Y, Shih IM, Wang TL (2019) Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions. J Pathol 248:41–50. https://doi.org/10.1002/path.5219
Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18:99–115. https://doi.org/10.1038/s41573-018-0004-1
Alkasalias T, Moyano-Galceran L, Arsenian-Henriksson M, Lehti K (2018) Fibroblasts in the tumor microenvironment: shield or spear? Int J Mol Sci 19(5):1532. https://doi.org/10.3390/ijms19051532
Wang L, Zhang F, Cui JY, Chen L, Chen YT, Liu BW (2018) CAFs enhance paclitaxel resistance by inducing EMT through the IL6/JAK2/STAT3 pathway. Oncol Rep 39:2081–2090. https://doi.org/10.3892/or.2018.6311
Zhao L, Ji G, Le X, Luo Z, Wang C, Feng M, Xu L, Zhang Y, Lau WB, Lau B, Yang Y, Lei L, Yang H, Xuan Y, Chen Y, Deng X, Yi T, Yao S, Zhao X, Wei Y, Zhou S (2017) An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis. Oncogene 36:3384–3396. https://doi.org/10.1038/onc.2016.487
Mitra AK, Zillhardt M, Hua Y, Tiwari P, Murmann AE, Peter ME, Lengyel E (2012) MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. Cancer Discov 2:1100–1108. https://doi.org/10.1158/2159-8290.CD-12-0206
Pang W, Su J, Wang Y, Feng H, Dai X, Yuan Y, Chen X, Yao W (2015) Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts. Cancer Sci 106:1362–1369. https://doi.org/10.1111/cas.12747
Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582–598. https://doi.org/10.1038/nrc.2016.73
Huang H, Brekken RA (2020) Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer. Am J Physiol Cell Physiol 319:C233–C243. https://doi.org/10.1152/ajpcell.00079.2020
Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, Hynes RO, Jain RK, Janowitz T, Jorgensen C, Kimmelman AC, Kolonin MG, Maki RG, Powers RS, Pure E, Ramirez DC, Scherz-Shouval R, Sherman MH, Stewart S, Tlsty TD, Tuveson DA, Watt FM, Weaver V, Weeraratna AT, Werb Z (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20:174–186. https://doi.org/10.1038/s41568-019-0238-1
Franco OE, Shaw AK, Strand DW, Hayward SW (2010) Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 21:33–39. https://doi.org/10.1016/j.semcdb.2009.10.010
Ireland LV, Mielgo A (2018) Macrophages and fibroblasts, key players in cancer chemoresistance. Front Cell Dev Biol 6:131. https://doi.org/10.3389/fcell.2018.00131
Kenny HA, Krausz T, Yamada SD, Lengyel E (2007) Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer 121:1463–1472. https://doi.org/10.1002/ijc.22874
Shan T, Chen S, Chen X, Lin WR, Li W, Ma J, Wu T, Cui X, Ji H, Li Y, Kang Y (2017) Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism. Oncol Rep 37:1971–1979. https://doi.org/10.3892/or.2017.5479
Horie M, Saito A, Yamaguchi Y, Ohshima M, Nagase T (2015) Three-dimensional co-culture model for tumor-stromal interaction. J Vis Exp 15(5):353–364. https://doi.org/10.3791/52469
Langhans SA (2018) Three-dimensional in vitro cell culture models in drug discovery and drug repositioning. Front Pharmacol 9:6. https://doi.org/10.3389/fphar.2018.00006
Chitty JL, Skhinas JN, Filipe EC, Wang S, Cupello CR, Grant RD, Yam M, Papanicolaou M, Major G, Zaratzian A, Da Silva AM, Tayao M, Vennin C, Timpson P, Madsen CD, Cox TR (2020) The mini-organo: a rapid high-throughput 3D coculture organotypic assay for oncology screening and drug development. Cancer Rep 3:e1209. https://doi.org/10.1002/cnr2.1209
Kenny HA, Lal-Nag M, Shen M, Kara B, Nahotko DA, Wroblewski K, Fazal S, Chen S, Chiang CY, Chen YJ, Brimacombe KR, Marugan J, Ferrer M, Lengyel E (2020) Quantitative high-throughput screening using an organotypic model identifies compounds that inhibit ovarian cancer metastasis. Mol Cancer Ther 19:52–62. https://doi.org/10.1158/1535-7163.MCT-19-0052
Truskey GA (2010) Endothelial cell vascular smooth muscle cell co-culture assay for high throughput screening assays for discovery of anti-angiogenesis agents and other therapeutic molecules. Int J High Throughput Screen 2010:171–181. https://doi.org/10.2147/IJHTS.S13459
Sharon Y, Alon L, Glanz S, Servais C, Erez N (2013) Isolation of normal and cancer-associated fibroblasts from fresh tissues by Fluorescence Activated Cell Sorting (FACS). J Vis Exp:e4425. https://doi.org/10.3791/4425
Castello-Cros R, Cukierman E (2009) Stromagenesis during tumorigenesis: characterization of tumor-associated fibroblasts and stroma-derived 3D matrices. Methods Mol Biol 522:275–305. https://doi.org/10.1007/978-1-59745-413-1_19
Proia DA, Kuperwasser C (2006) Reconstruction of human mammary tissues in a mouse model. Nat Protoc 1:206–214. https://doi.org/10.1038/nprot.2006.31
Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, Bonneau C, Kondratova M, Kuperstein I, Zinovyev A, Givel AM, Parrini MC, Soumelis V, Vincent-Salomon A, Mechta-Grigoriou F (2018) Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33:463–479.e10. https://doi.org/10.1016/j.ccell.2018.01.011
Acknowledgments
We would like to thank all of the members of the Lengyel Ovarian Cancer Research Laboratory at the University of Chicago for their helpful comments and feedback. In particular, we thank Dr. Abir Mukherjee for his assistance. M.A.E. was supported by the Ovarian Cancer Research Alliance (OCRA) Liz Tilberis Early Career Award 650339.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zawieracz, K., Eckert, M.A. (2022). Isolation of Normal and Cancer-Associated Fibroblasts. In: Kreeger, P.K. (eds) Ovarian Cancer. Methods in Molecular Biology, vol 2424. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1956-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1956-8_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1955-1
Online ISBN: 978-1-0716-1956-8
eBook Packages: Springer Protocols